News

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...
We provide a methodology for selecting high-growth dividend-paying stocks. Click here to read more about the basis of the ...
The market and broader economy are stabilizing, setting the stage for a more “risk-on” outlook for the second half after 2025 ...
"I like to help women feel comfortable and confident and get rid of the taboo and stigma that they might feel with normal, ...
BioGaia AB (BIOGY) reports robust sales growth in Asia Pacific and adult health segments, while facing challenges with increased operating expenses and declining EBIT margins.
Manchester City are trying to sell two attacking midfielders this summer but one is proving more popular than the other, when ...
Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...
Nokian Tyres plc Stock Exchange Release July 18, 2025, at 1:30 p.m. EESTNOKIA, Finland, July 18, 2025 /PRNewswire/ -- To reflect our shar ...
Business and Financial Times on MSN4d
Professionalism in banking
By Robert Owusu, FCIB Developing and sustaining professional behaviours is critical to any job success. Employers expect ...
After nearly four beautiful soul-stretching years, Ami Colé will close this September. This decision was so hard for me — the business bears my mother’s name and, as I built it, my daughter’s name, ...
CVS Health (CVS) closed the most recent trading day at $61.96, moving -2.12% from the previous trading session. This change lagged the S&P 500's 0.01% loss on the day. Elsewhere, the Dow lost 0.32%, ...
The consensus mark for earnings is pegged at $5.22 per share, indicating a 2.8% decline from the year-ago quarter’s reported ...